Effect of Hydrocortisone on Development of Shock Among Patients With Severe Sepsis
Didier Keh(Charité - Universitätsmedizin Berlin), Holger Bogatsch, Sven Bercker, A. Weyland(Carl von Ossietzky Universität Oldenburg), Markus Loeffler, Josef Briegel(Ludwig-Maximilians-Universität München), Christoph Engel, Andreas Meier‐Hellmann(Helios Klinikum Erfurt), Axel Nierhaus(Universität Hamburg), Dirk Schädler, Tobias Schuerholz(RWTH Aachen University), Josefa Lehmke(Vivantes Klinikum), Sven‐Olaf Kuhn(Universität Greifswald), Evelyn Trips, Kerstin Resener(Helios Hospital Berlin-Buch), Gernot Marx(RWTH Aachen University), Frank M. Brunkhorst, Lars Hüter(Zentralklinik Bad Berka), Emad Abduljawwad(Helios Hospital Bad Saarow), Stefan Kluge(Universität Hamburg), Philipp Simon(University Hospital Leipzig), Konrad Reinhart(Jena University Hospital), Norbert Weiler, Michael Oppert(Klinikum Ernst von Bergmann), Stefan P. Wirtz(Helios Hospital Bad Saarow), Herwig Gerlach(Vivantes Klinikum), Anton Goldmann(Charité - Universitätsmedizin Berlin)
Cited by 265
Related Papers
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Intensive Care Medicine|2017|6.8k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Critical Care Medicine|2017|3.8k
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19
|Annals of Internal Medicine|2020|2.4k
Multiorgan and Renal Tropism of SARS-CoV-2
|New England Journal of Medicine|2020|1.9k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k